| Price | 1,920.50p on 20-08-2026 at 18:35:07 |
|---|---|
| Change | 4.50p 0.23% |
| Buy | 1,923.00p |
| Sell | 1,922.00p |
| Last Trade: | Buy 216.00 at 1,920.50p |
| Day's Volume: | 8,380,816 |
| Last Close: | 1,920.50p |
| Open: | 1,927.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,902.00p - 1,936.50p |
| 52wk Range: | 1,440.50p - 2,282.00p |
| Market Capitalisation: | £76.93b |
| VWAP: | 1,924.19493p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 216 | 1,920.50p | Automatic Execution |
16:39:17 - 20-Aug-26 |
| Buy* | 1,462 | 1,920.50p | Automatic Execution |
16:39:17 - 20-Aug-26 |
| Buy* | 916 | 1,920.50p | Automatic Execution |
16:39:17 - 20-Aug-26 |
| Buy* | 67 | 1,920.50p | SI Trade |
16:38:05 - 20-Aug-26 |
| Buy* | 762 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
| Buy* | 38 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
| Buy* | 600 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
| Buy* | 200 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
| Buy* | 200 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
| Buy* | 200 | 1,920.50p | Automatic Execution |
16:37:41 - 20-Aug-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 13th Aug 2026 3:33 pm | RNS | Director/PDMR Shareholding |
| 11th Aug 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 3rd Aug 2026 3:00 pm | RNS | Total Voting Rights |
| 30th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 28th Jul 2026 12:05 pm | RNS | New GSK flagship R&D centre in Cambridge |
| 28th Jul 2026 12:00 pm | RNS | 2nd Quarter Results |
| 28th Jul 2026 11:06 am | RNS | Hansoh positive 2nd Phase III results for Riz-Rez |
| 24th Jul 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jul 2026 3:00 pm | RNS | Admission to Trading |
